Tatva Chintan Pharma Chem Q3 FY24 consolidated PAT drops to Rs. 3.45 Cr

Tatva Chintan Pharma Chem Q3 FY24 consolidated PAT drops to Rs. 3.45 Cr

By: IPP Bureau

Last updated : January 22, 2024 11:12 am



Tatva Chintan Pharma Chem has reported total income of Rs. 85.41 crores during the period ended December 31, 2023


Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended December 31, 2023.

Tatva Chintan Pharma Chem has posted net profit of Rs. 3.45 crores for the period ended December 31, 2023 as against net profit of Rs. 7.78 crores for the period ended September 30, 2023. The company posted net profit of Rs.11.62 crores for the period ended December 31, 2022.

Tatva Chintan Pharma Chem has reported total income of Rs. 85.41 crores during the period ended December 31, 2023 as compared to Rs. 97.42 crores during the period ended September 30, 2023. The company reported total income of Rs.121.68 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Tatva Chintan Pharma Chem has reported total income of Rs.298.21 crores, 2023 as compared to Rs.303.99 crores during the 9 months period ended December 31, 2022.

The company has posted net profit of Rs.20.74 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.28.52 crores for the 9 months period ended December 31, 2022.

Tatva Chintan Pharma Chem Ltd

First Published : January 22, 2024 12:00 am